// App-Quantinova.ai

2491 : Real-World Effectiveness and Safety of Subcutaneous Abatacept in Biologic-Naive Vs. Biologic-Experienced RA Patients: The Abatacept Best Care Study

Researchers

Presenter

  • B Haraoui

Principal Investigators

  • Janet E. Pope

  • Isabelle Fortin

  • Emmanouil Rampakakis

  • John S. Sampalis

  • Francoise Romeyer

  • Joseph Atallah

  • Louis Bessette

Medical Centers

  • Institut de Recherche en Rhumatologie de Montreal, Montreal, Canada

  • Department of Medicine, Division of Rheumatology, University of Western Ontario, St. Joseph’s Health Care, London, ON, Canada,

  • Centre de Rhumatologie de -Est du Quebec, Rimouski, QC, Canada

  • JSS Medical Research, Montreal, QC, Canada

  • Montreal University, Montreal, QC, Canada

  • JSS Medical Research, St-Laurent, QC, Canada

  • Bristol-Myers Squibb, Montreal, QC, Canada

  • Centre -Osteoporose et de Rhumatologie de Quebec CORQ, Quebec, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Abatacept

Outcome

  • N/A

Study Design

  • Randomized

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved